<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0003613'>Antiphospholipid antibody</z:hpo> syndrome (APS) is a systemic <z:e sem="disease" ids="C0004364" disease_type="Disease or Syndrome" abbrv="">autoimmune disorder</z:e> characterized by venous and/or <z:hpo ids='HP_0004420'>arterial thrombosis</z:hpo> or recurrent fetal loss associated with the presence of <z:hpo ids='HP_0003613'>antiphospholipid antibodies</z:hpo> and/or a <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> </plain></SENT>
<SENT sid="1" pm="."><plain>The skin appears to be an important target organ and many cases of APS may present with skin manifestations </plain></SENT>
<SENT sid="2" pm="."><plain>These lesions may be manifold and may take the form of <z:hpo ids='HP_0000965'>livedo reticularis</z:hpo>, <z:e sem="disease" ids="C0085642" disease_type="Disease or Syndrome" abbrv="">livedo racemosa</z:e>, ulcerations, digital <z:hpo ids='HP_0100758'>gangrene</z:hpo>, subungeal splinter <z:mp ids='MP_0001914'>hemorrhages</z:mp>, superficial <z:hpo ids='HP_0004936'>venous thrombosis</z:hpo>, thrombocytopenic <z:hpo ids='HP_0000979'>purpura</z:hpo>, pseudovasculitic manifestations, extensive cutaneous <z:mp ids='MP_0001651'>necrosis</z:mp>, or <z:e sem="disease" ids="C0406550" disease_type="Disease or Syndrome" abbrv="">primary anetoderma</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>We report a case of fulminant APS-related cutaneous <z:mp ids='MP_0001651'>necrosis</z:mp> </plain></SENT>
<SENT sid="4" pm="."><plain>A 38-year-old Caucasian male with a past history of APS, multiple deep vein <z:e sem="disease" ids="C0087086" disease_type="Disease or Syndrome" abbrv="">thrombi</z:e>/<z:e sem="disease" ids="C0034065" disease_type="Disease or Syndrome" abbrv="">pulmonary emboli</z:e>, presented with necrotic lesions on his right upper and right lower extremities </plain></SENT>
<SENT sid="5" pm="."><plain>Initially, baseline anticoagulation was increased without improvement </plain></SENT>
<SENT sid="6" pm="."><plain>Subsequently, plasma exchange was initiated on a daily schedule </plain></SENT>
<SENT sid="7" pm="."><plain>Furthermore, rituximab 1,000 mg IV was administered on days 1 and 15 </plain></SENT>
<SENT sid="8" pm="."><plain>After six consecutive daily sessions of plasma exchange, there was significant regression of the necrotic lesions </plain></SENT>
<SENT sid="9" pm="."><plain>After a 22-day hospital stay, the patient was discharged to home on fondaparinux </plain></SENT>
<SENT sid="10" pm="."><plain>The patient presented approximately 2 months later after missing follow-up appointments </plain></SENT>
<SENT sid="11" pm="."><plain>At the time, his initial lesions looked remarkably improved </plain></SENT>
</text></document>